TY - GEN
T1 - Risk-stratification of lung cancer using buccal nanocytology
AU - Subramanian, H.
AU - Viswanathan, P.
AU - Iyengar, R.
AU - Cherkezyan, L.
AU - Verleye, M.
AU - Rozhok, S.
AU - Gandhi, A.
AU - Derbas, J.
AU - Czarnecki, J.
AU - Roy, H. K.
AU - Backman, V.
N1 - Publisher Copyright:
© OSA 2016.
PY - 2016/4/18
Y1 - 2016/4/18
N2 - Buccal nanocytology is employed in the development of a primary care physician's office based, low cost, minimally intrusive and accurate risk stratification test for lung cancer among current and former smokers.
AB - Buccal nanocytology is employed in the development of a primary care physician's office based, low cost, minimally intrusive and accurate risk stratification test for lung cancer among current and former smokers.
UR - http://www.scopus.com/inward/record.url?scp=85019503008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019503008&partnerID=8YFLogxK
U2 - 10.1364/TRANSLATIONAL.2016.TTh3B.4
DO - 10.1364/TRANSLATIONAL.2016.TTh3B.4
M3 - Conference contribution
AN - SCOPUS:85019503008
SN - 9781943580101
T3 - Optics InfoBase Conference Papers
BT - Clinical and Translational Biophotonics, Translational 2016
PB - OSA - The Optical Society
T2 - Clinical and Translational Biophotonics, Translational 2016
Y2 - 25 April 2016 through 28 April 2016
ER -